A compound according to formula I: or a pharmaceutically acceptable salt thereof; wherein R1, R2, R3a, R3b, R3c and R3d are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
申请公布号
BRPI0821573(A2)
申请公布日期
2016.08.09
申请号
BR2008PI21573
申请日期
2008.12.22
申请人
EXELIXIS INC.
发明人
ADAM ANTONI GALAN;AMY L. TSUHAKO;CRISTINA A. ZAHARIA;ELENA S. KOLTUN;HONGWANG DU;MAURIZIO FRANZINI;MOON HWAN KIM;PATRICK KEARNEY;PING HUANG;S. DAVID BROWN;STEVEN JAMES RICHARDS
